Week 5.1
EATING DISORDERS
TYPES
Anorexia Nervosa
Bulimia Nervosa
Binge Eating Disorder
Obesity
ANOREXIA NERVOSA
Characterized by a morbid fear of obesity.
Symptoms include:
Gross distortion of body image
Preoccupation with food
Refusal to eat
Weight loss can be excessive, with some individuals presenting for healthcare services weighing less than 85% of expected weight.
Associated symptoms and health issues:
Hypothermia
Bradycardia
Hypotension
Edema
Lanugo (soft, fine hair)
Metabolic changes
Anxiety and depression
BULIMIA NERVOSA
Characterized by episodic, uncontrolled, and compulsive rapid ingestion of large quantities of food over a short period, known as bingeing.
Followed by inappropriate compensatory behaviors to rid the body of the excess calories, which may include:
Self-induced vomiting
Misuse of laxatives, diuretics, or enemas
Physical consequences of Bulimia:
Leads to dehydration and electrolyte imbalances.
Fasting or excessive exercise as additional compensatory behaviors.
Individuals may be within the normal weight range, some slightly underweight, or some slightly overweight.
Mental health comorbidities such as depression, anxiety, and substance abuse are not uncommon.
BINGE EATING DISORDER (BED)
Can lead to obesity.
Involves episodes of binge eating similar to bulimia nervosa.
Key differences:
Does NOT engage in behaviors to rid the body of excess calories post-binge.
Approximately 50% of individuals with BED have a history of depression.
RISK FACTORS / CAUSES
Genetic factors:
More prevalence observed among sisters and mothers of affected individuals.
Possible chromosomal linkage.
Possible hypothalamic dysfunction.
Neurotransmitter abnormalities:
Alterations in serotonin and norepinephrine levels may contribute. (risk for depression)
GOALS OF TREATMENT
Achieve and maintain at least 80% of expected body weight.
Ensure vital signs, blood pressure, and laboratory serum studies are within normal limits.
Patient should verbalize the importance of adequate nutrition for health.
Understand consequences of fluid loss due to self-induced vomiting or laxative/diuretic abuse and recognize the importance of fluid intake.
Identify precursors to anxiety and demonstrate techniques for its reduction.
Express an interest in the welfare of others, reducing self-preoccupation regarding physical appearance.
Correct misperceptions regarding body image, demonstrating control over their life without maladaptive eating behaviors (specific to anorexia nervosa).
Establish healthy eating patterns aimed at weight control and progression towards desired weight goals (specific to BED).
Create plans for future weight maintenance (specific to BED).
HOSPITALIZATION
May be necessary in severe cases due to:
Malnutrition
Dehydration
Severe electrolyte imbalance
Cardiac arrhythmias or severe bradycardia
Hypothermia
Hypotension
Suicidal ideation
NURSING DIAGNOSIS / PLANNING
Identify problems:
Imbalanced nutrition/deficit fluid volume, defined as an intake of nutrients insufficient to meet metabolic needs.
Deficient fluid volume, indicated by decreased intravascular, interstitial, and/or intracellular fluid.
Disturbed body image and low self-esteem.
Plan must include determining appropriate calorie intake to support adequate nutrition and weight gain.
Focus should not solely be on food and eating; also include psychological aspects.
Keep strict records of intake and output.
DENIAL
Defined as a conscious or unconscious attempt to disavow the knowledge or meaning of an event to mitigate anxiety and/or fear, which can negatively impact health.
Establish a trusting relationship with clients.
Avoid arguments or bargaining with the client as a method of conflict resolution.
TREATMENT
Emphasizes patient-centered care approaches, allowing patients input into their care plans.
Help patients understand their control in treatment decisions, particularly around eating behaviors, exercise, and choices regarding vomiting.
Implement a rewards system to positively reinforce healthy behaviors.
Incorporate individual therapy, family therapy, and cognitive-behavioral therapy (CBT) in conjunction with medications as necessary, which have been shown to be more beneficial.
MEDICATIONS
Commonly prescribed medications for anorexia nervosa include:
Fluoxetine (Prozac): An SSRI used for depression and anxiety that may help with weight restoration.
Clomipramine (Anafranil): A tricyclic antidepressant that may also reduce obsessive thoughts related to food.
Cyproheptadine (Pariactin): An antihistamine that can increase appetite.
Chlorpromazine (Thorazine): An antipsychotic that may be utilized for severe anxiety.
Olanzapine (Zyprexa): An atypical antipsychotic that may aid in treatment and weight gain.
For bulimia nervosa
Fluoxitine (Prozac) : It's an SSRI that can help reduce binge-eating and vomiting episodes, often prescribed at higher doses than for depression
Imipramine (Tofranil) : A tricyclic antidepressant (TCA) that can help reduce binge-purge cycles. TCAs affect norepinephrine and serotonin levels.
Desipramine (Norpramine): Another TCA, potentially effective in reducing bingeing and vomiting behaviors, often chosen for its milder side effect profile compared to some other TCAs.
Amitryptyline (Elavil) : A TCA with sedative properties, which may be beneficial if insomnia is also present. It can help reduce binge-purge frequency.
Nortriptyline (Aventyl): A less sedating TCA, also used for its antidepressant effects and potential to decrease bulimic symptoms.
Phenelzine (Nardil) : A monoamine oxidase inhibitor (MAOI) that has shown efficacy in reducing bulimic symptoms, but it requires strict dietary restrictions to prevent hypertensive crisis and is typically reserved for cases resistant to other treatments.
For BED wtih obesity
Topiramate (Topamax) : An anticonvulsant medication that can help reduce binge eating episodes and frequently leads to weight loss. Its mechanism for BED is not fully understood, but it may involve modulation of neurotransmitters.
Lisdexamfetamine : The first medication specifically approved by the FDA for the treatment of moderate to severe binge eating disorder in adults. It's a stimulant that works by affecting neurotransmitters in the brain involved in impulse control and appetite regulation.